spacer
home > pmps > spring 2007 > clean and in control
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Clean and in Control

Colin Booth at Oxoid Limited, explores how aseptic processing demonstrates process control through simulation and monitoring

Increasingly, pharmaceutical companies are depending on aseptic techniques to ensure the sterility of products. As aseptic processing becomes more commonplace, it is important that we remember the significance of each individual aspect of control and how they relate to each other. This article discusses the roles of monitoring and process simulations in demonstrating aseptic process control.

Sterility is defined as the absence of microbial contaminants. Many products can be sterilised by heat or irradiation, but some are sensitive to such extremes and require aseptic processing to ensure the risks of microbial contamination are minimised, if not eliminated. Maintenance of aseptic conditions involves a careful balance of control measures, each of which must be individually validated and monitored. All are equally important; if a single system fails to do what is expected, it can result in loss of control for the entire process.

Some of the most significant processes used to eliminate the risk of microbial contamination in aseptic processing include:

  • Designated cleanrooms and support areas
  • Minimal human intervention – and, where it cannot be avoided, the training and qualification of employees and the use of suitable gowns and gloves for example
  • HEPA filtered air – supplied under laminar flow to direct air flow away from critical steps, such as point-of-fill
  • Positive air pressure – to minimise the movement of air into the cleanroom area
  • Sterilisation of everything brought into the cleanroom – including steam sterilisation of vials and seals, and filter sterilisation of the final product, for example. The obvious exception to this rule is people – one of the most frequent sources of contamination! Since operators cannot be sterilised, every precaution must be taken to ensure that risks are minimised
  • Cleaning, sanitisation and disinfection procedures

All of these processes must be validated and monitored to ensure they are working correctly. For example, air pressure and air flow should be monitored continuously against suitable alert and action levels to allow time to rectify a problem before any damage is done. The entire process should be supported by a thorough environmental monitoring programme and ultimately validated using process simulations or media fill trials (MFTs).


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Colin Booth, Vice President Science and Technology at Oxoid, has over 30 years’ experience in pharmaceutical microbiology. He has worked for some of the world’s pharmaceutical giants, such as ICI Pharmaceuticals (now Astra Zeneca), Glaxo, Glaxo Wellcome and GlaxoSmithKline. In 2002 he joined global culture media and diagnostic test manufacturer, Oxoid in his current role and is based at their headquarters in Basingstoke, UK.
spacer
Colin Booth
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

MedPharm accelerates strategy to broaden service offering into commercial manufacturing

MedPharm Ltd, a leading contract provider of topical and transdermal product design and development services, has announced two new appointments to its Board to support plans to grow its commercial manufacturing services.
More info >>

White Papers

Autoinjector testing made safe efficient and flexible

ZwickRoell

The autoinjector market is one of the fastest growing markets across almost all pharmaceutical applications. Studies expect a global market volume of approximately USD 2.5 billion by 2020, with pre-filled autoinjectors representing the largest market segment. There are a variety of tests that can be performed on autoinjectors, and these are well-demonstrated by the Zwick product portfolio. The Ulm-based company and specialist in testing systems offers a variety of testing systems that are already being successfully used by multiple pharmaceutical companies.
More info >>

 
Industry Events

CPhI & P-MEC China

18-20 June 2019, SNIEC, Shanghai, China

CPhI & P-MEC China 2019 is your gateway to successfully grow your business at the 2nd largest pharma market in the world. Whether you are looking for sourcing new business or getting the latest market insight, this is your one-stop shop pharmaceutical platform in Asia.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement